CI (Cigna Corporation) is set to report its earnings on May 05, and the financial world is anticipating a 6.45% increase in earnings to $5.28 per share. This news has generated a lot of buzz among investors and analysts, who are closely monitoring the company's financial performance.
Managed Health Care Industry is on the rise, and one stock that stands out is Alignment Healthcare (ALHC) with an impressive 18.23% weekly gain. But what's driving this growth? A closer look at ALHC's technical indicators and recent earnings report reveals a compelling story for traders and investors. Read on to find out more
On Tuesday, February 21, Walmart will be announcing its earnings forecast for the upcoming year. This is a highly anticipated event, as Walmart is one of the largest retailers in the world, and its performance often reflects broader trends in the global economy. Walmart's most recent earnings report, released in November 2022, showed strong growth in e-commerce sales, which increased by 43%...
UnitedHealth Group posted fourth quarter earnings that exceeded analysts’ expectations. UnitedHealth’s adjusted profits for the three months ended in September came in at $5.34 a share, 17 cents ahead of the Wall Street consensus forecast. Revenues climbed +12.3% to $82.8 billion, vs. analysts’ estimates of $82.6 billion. Optum revenue climbed +16.5% to $47.9 billion. UnitedHealth's medical...
Cigna Corp. Q2 adjusted earnings came in at $6.22 a share, surpassing analysts’ expectations of $5.49 a share ( based on FactSet poll). The healthcare company's revenue climbed +5.45% year-over-year to $45.48 billion vs. analysts’ estimates of $44.49 billion, (according to FactSet). Evernorth segment, which covers pharmacy services, benefits management, care solutions and data and analytics,...
UnitedHealth Group Inc. reported its second-quarter adjusted earnings that exceeded analysts’ expectations. The company also boosted its earnings guidance for the full year. UnitedHealth’s adjusted earnings came in at $5.57 a share, exceeding the $5.21 a share expected by analysts surveyed by FactSet. Revenue of $80.3 billion also beat analysts’ forecasts for $79.7 billion (according to...
Now MIT researchers have developed a machine-learning algorithm that registers 3D images (like brain scans) 1000-plus times more quickly than traditional methods.
Traditionally, 3D images are created via a technique called medical image registration.This process overlays two images, like MRIs, to compare and contrast anatomical information in great detail – an especially useful tool for doctors to gauge progress with a patient or treatment.
MRI (magnetic resonance imaging) scans consist of hundreds of 2D images, all stacked on top of each other to form 3D images.
CVS Health Corp. reported fourth quarter earnings that exceeded analysts’ expectations. The healthcare company said it will resume offering insurance plans that offer 'Obamacare' subsidies. The company’s adjusted earnings for the three months ending in December fell -25% rom the year-ago quarter to $1.30 per share, 6 cents ahead of the Street consensus forecast. Revenues increased +4%...
The deal is expected to close in the second half of 2021.
The acquisition will see Change Healthcare combining with UnitedHealth’s OptumInsight unit to offer data analytics, software and other services to the health-care industry.
According to the two companies, the deal will help simplify services around medical care and lower costs.
Private-equity funds affiliated with Blackstone Group that own about 20% of Change Healthcare’s common stock have agreed to vote in favor of the deal.The deal is expected to increase UnitedHealth’s adjusted per-share earnings by 50 cents in 2022, the companies said.
The healthcare company also boosted its full-year profit guidance.
The company’s adjusted earnings for the three months ending in September came in at $1.84 per share, higher than analyst’ estimate of $1.77 per share.The figure reflects growth of +6.35% from the same period last year.
CVS total revenues surged +36.5% year-over-year to $64.8 billion in the quarter, again exceeding analysts' expectation of $63 billion.
On a segment level, Pharmacy Services revenues rose +6.5%, on brand name drug price inflation as well as increased total pharmacy claims volume, partially offset by continued price compression and an increased generic dispensing rate – as indicated by the company.
Healthcare provider Centene (NYSE: CNC) provides programs and services to under-insured and uninsured individuals in the United States.The company is set to release third quarter earnings results on October 22, but the stock ran in to some resistance ahead of the report.
The daily chart shows that the stock has been trending lower over the last five months with a trend channel forming that defines the various cycles within the trend.
UnitedHealth shares was downgraded by Jefferies, on concerns related to political risks and competition.
Jefferies analyst David Windley lowered his rating on the healthcare company to hold from buy citing "the primary poison in the punch bowl, political risk, won't likely abate for at least another nine months."
Windley also indicated that UnitedHealth faces tough competition from Anthem, especially since the latter's market share is expanding while the two companies' geographies overlap.
The analyst also cut his price target on UnitedHealth shares to $235 a share from $300.
According to a group of Citigroup analysts, Cigna is "one of the most compelling stocks and stories" they have seen across 20 years on the sell side.
The group of analysts feels that the health services company has the right goals coupled with a strong historical performance, a solid strategy, improved positioning, and a balanced growth outlook – while having a low valuation.
Analyst Ralph Giacobbe mentioned that Cigna is trading at a 27% discount to peers and 49% discount to the market.
Citigroup gave Cigna shares a “buy” rating.The target indicates upside of 31% from Wednesday's close price.
However, Giacobbe did mention that the outlook is not without a few risks, such as a potential unexpected increase in healthcare-costs, heated competition from peers, the risks inherent in integrating Express Scripts, and general headline risks from the focus on drug pricing and the evolving pharmacy-benefit-manager model.
CVS Health Corp. topped second quarter earnings expectations and raised its full-year profit guidance, leading to a climb in its stock price Wednesday.
For the three months ending June, the retail pharmacy and pharmacy benefit manager reported adjusted earnings of $1.89 per share, marking a +11.8% increase from the year-ago quarter and a significant beat on the Street estimate of $1.69 per share.
Total revenues for the quarter climbed +35.2% year-over-year to $63.4 billion, also exceeding analysts' forecasts of $62.66 billion.Sales from Aetna (which CVS acquired in 2018) emerged as a significant contributor to the overall revenue growth.
Revenues from Pharmacy Services rose +4.2% to $34.8 billion.
UnitedHealth Group's earnings for the three months ending in June came in higher than expected, and the company also boosted its full-year profit guidance.However, the company cautioned about a possible miss on 2019 revenue forecasts.
The healthcare company reported adjusted earnings of $3.60 per share for the quarter, which is 15 cents ahead of the Street consensus forecast. The earnings per share figure also reflects a +14.6% increase from the same period last year.
Total revenues of the company rose +8% to $60.6 billion, largely in-line with analysts' estimates.
Looking ahead, UnitedHealth expects its full-year net adjusted net earnings to be in the range of $14.70 to $14.90 per share, which is a small upgrade to the company's prior expectation.
However, CFO John Rex told investors that 2019 revenues would be "at or just slightly below" the forecast range of $243 billion to $245 billion.
CVS will offer expanded health services such as nutrition counseling and blood pressure screenings in 1,500 stores by the end of 2021.
The company plans to convert a total of 50 stores this year in Houston, Atlanta, Philadelphia, and Tampa, representing about 15% of the stores in each of the markets.
The company also said it expects adjusted earnings of over $7 per share in 2020 while reiterating its profit and sales forecast for 2019.Analysts on average expect a profit of $7.22 per share for 2020.
CVS will open 1,500 HealthHUB stores by the end of 2021, the company announced Tuesday ahead of its investor day.
Health insurance provider UnitedHealth Group (NYSE: UNH) has been trending lower since early December.The stochastic readings made a bearish crossover on May 23.
The Tickeron AI Trend Prediction Engine generated a bearish signal on UnitedHealth Group on May 22.
The stock has been trending lower since the beginning of December and has not been able to shake its downtrend the way the rest of the market has.
Looking at the daily chart, connecting the highs from December and February we get the upper rail of a downward sloping trend channel.We saw a similar scenario in April before the stock dropped over 20%.
The Tickeron AI Prediction tool generated a bearish signal toward Centene on May 8.
Judge Richard Leon of the U.S. District Court for the District of Columbia, who has been asked to sign off on a government agreement that allowed CVS Health Corp. to buy Aetna, ordered a hearing for April 5.
He said that he wanted the hearing to discuss which witnesses, if any, should testify before he decides whether to approve the government’s deal with the companies.
The $69 billion transaction closed in November. The Justice Department approved the merger of CVS and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc. That deal has also closed.